Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.11 | -0.14 | 0.00 |
| EPS, GAAP | -0.55 | -0.14 | -0.14 |
| Consensus Estimate | -0.15 | -0.14 | 9.29 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -0.48 | -0.48 | 17.31 |
| EPS, GAAP | -0.48 | -0.48 | 14.00 |
| Consensus Estimate | -0.63 | -0.43 | 46.67 |
| ALKS | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.17 |
| Price/Sales | 4.77 | 4.18 |
| Beta | 1.01 | 0.62 |
| 5/22/2012 | Eaton's Cooper Pact Swaps U.S. Tax Rate for Ireland's (WSJ.com) |
| 3/28/2012 | The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS) (24/7 Wall St) |
| 3/27/2012 | MAP gets a CRL, but Levadex lives to fight another day. (The Motley Fool) |
| 3/1/2012 | Elan Keeps Pilot in Place (WSJ.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
